|
Following
a lumpectomy, radiation therapy confined to that immediate part
of the breast may be as effective as radiation treatment of the
entire breast for preventing recurrence of early-stage breast
cancer, according to a report in the Journal of the National Cancer
Institute.
Researchers
at William Beaumont Hospital in Royal Oak, Michigan, seeking to
determine the optimal volume of breast tissue requiring post-lumpectomy
radiation therapy, compared outcomes for 199 women who received
radiation therapy limited to the region of the tumor to 199 women
who underwent whole breast radiation therapy.
The women
receiving what is called "limited-field radiation therapy"
were treated with interstitial brachytherapy, a technique in which
radioactive material is inserted into the breast around the site
of a lumpectomy.
After a median-followup
period of 65 months, "the rate of local recurrence was not
statistically significantly different between the patient groups
-- one percent for the whole-breast radiation therapy patients
versus one percent for the limited-field radiation therapy patients,"
the researchers reported.
"Limited-field
radiation therapy administered to the region of the tumor bed
has comparable 5-year local control rates to whole-breast radiation
therapy in selected patients," the researchers concluded.
In an accompanying
commentary, Dr. C. Norman Coleman of the National Cancer Institute
said a clinical trial now is needed to "provide definitive
answers for those physicians and patients yet to face the decision
about treatment options for early stage breast cancer."
Other
Sources: Journal of the National Cancer Institute
|